Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02403843 · ClinicalTrials.gov registry record
RNS® System Epilepsy Post-Approval Study
A clinical trial of Epilepsy, sponsored by NeuroPace.
- Active
- Registry status
- 375
- Enrollment target
- 20
- Study locations
NCT02403843 is a study of Epilepsy that is active but no longer recruiting, run by NeuroPace. The registered enrollment target is 375 participants, below the 950-participant average among 160 other Epilepsy trials with a reported enrollment target (61% lower). The trial reports 20 study locations across 15 states.
The verdict
NCT02403843, a study of Epilepsy, is active but no longer recruiting, sponsored by NeuroPace.
- ACTIVE NOT RECRUITING
- Registry status
- 375 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the study is to follow patients with partial onset seizures prospectively over 5 years in the real-world environment to gather data on the long-term safety and effectiveness of the RNS System at qualified CECs by qualified neurologists, epileptologists, and neurosurgeons trained on the RNS System.
Conditions Studied
Interventions
- DEVICE RNS System
Study Locations (20)
California
- University of California, Irvine - Irvine
- University of Southern California - Los Angeles
- University of California, Los Angeles - Los Angeles
- Stanford University - Palo Alto
- University of California, San Francisco - San Francisco
Kentucky
- University of Kentucky - Lexington
- Norton Neuroscience Institute - Louisville
Alabama
- University of Alabama, Birmingham - Birmingham
Colorado
- University of Colorado Denver - Aurora
Connecticut
- Yale University - New Haven
Florida
- University of South Florida - Tampa
Georgia
- Emory University - Atlanta
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2015-06 |
| Est. Completion | 2026-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02403843
The ClinicalTrials.gov registry entry for NCT02403843 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 950-participant average among 160 other Epilepsy trials with a reported enrollment target (61% lower). The listed sponsor is NeuroPace, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which RNS System is the first listed.
NCT02403843 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Kentucky, Alabama.
Frequently Asked Questions
What is clinical trial NCT02403843 about?
NCT02403843 is a clinical study titled "RNS® System Epilepsy Post-Approval Study". The purpose of the study is to follow patients with partial onset seizures prospectively over 5 years in the real-world environment to gather data on the long-term safety and effectiveness of the RNS System at qualified CECs by qualified neurologists, epileptologists, and neurosurgeons trained on th...
What is the current status of trial NCT02403843?
This trial is currently active not recruiting. The enrollment target is 375 participants. The study started on 2015-06. Estimated completion is 2026-01.
What conditions does trial NCT02403843 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT02403843?
The interventions under investigation include: RNS System (DEVICE).
Who is sponsoring clinical trial NCT02403843?
This trial is sponsored by NeuroPace, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02403843 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.